Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Targeting Kv1.3 channels shows promise for treating autoimmune diseases

Nov. 24, 2006

orBec NDA accepted for review

Nov. 23, 2006

Roche to discontinue codevelopment of daclizumab for transplant maintenance

Nov. 23, 2006

First launch for Grazax

Nov. 22, 2006

ISA-247 shows good efficacy, maintains good kidney function in transplant patients

Nov. 17, 2006

VariZIG awarded orphan drug designation

Nov. 15, 2006

Prochymal shows good complete response rate in GVHD

Nov. 13, 2006

orBec filed in Europe for GI GVHD

Nov. 8, 2006

Novel immunosuppressant agents disclosed by Pharmacopeia

Nov. 7, 2006

VaxGen's second phase II trial of rPA-102 delayed by clinical hold

Nov. 7, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...